Market OverviewFinlify
Price Date: 2026/07/30
IBM logo

IBM - International Business Machines Corporation

A century-old technology giant reinventing itself as a hybrid cloud and AI services provider, with a focus on enterprise consulting through its Watson and Red Hat platforms.

AVOIDWeak Technical SetupCurrent data points to a weaker relative setup or heavier score deductions.
MEETMEET compares latest EPS results against analyst estimates.

Finlify Score

30.9 / 100

Data Quality

FULL

Penalty

0.0

Sector

Information Technology

Close Price

$221.74

-2.08%

52W Range

$199.19 - $332.46

Market Cap

$264.3B

-2.1%

Compared to previous day

2026 Q1 Revenue

$15.9B

-19.1%

Changes from last reporting quarter

2026 Q1 EPS

$1.28

Diluted shares

Analyst Rating

19 Buy9 Hold1 Sell

29 analysts in latest ratings feed

RSI

24.9

<40 oversold

2Y Range Position

27%

-33.3% from high / +22.0% from low

Beta

0.72

Relative to market benchmark

MACD

-0.53

MACD line -13.82 / signal line -13.29

Fundamental Trend

Growth 11.1
Revenue QoQ-19.1%
Revenue YoY+9.5%
EPS QoQ-78.3%
EPS YoY+14.3%
Gross margin QoQ-4.4%
Operating margin QoQ-
Net margin QoQ-20.8%

Financial Health

Quality 38.8
Debt / equity1.75x
Debt ratio+36.9%
Cash / debt proxy0.19x
Cash / assets+6.9%

Data Quality

FULL
As of date2026-07-30
Latest statement2026-03-31
Penalty0.0
Missing dataNone

Valuation Reference

P/E18.98x
P/B8.48x
P/S2.98x
EV / EBITDA22.34x

Price Chart

Close price, two-year source window

Finlify Score

AVOID

30.9 / 100

Relative Strength9.3 / 100
Accumulation & Volume96.3 / 100
Fundamental Trend11.1 / 100
Financial Quality38.8 / 100
Data Quality FULLNo penalty

Score History

Finlify Score and component trend

Financial Statements

Calendar year view. Figures are estimates only. For official figures, refer to the company website.

2026 Q12025 Q42025 Q32025 Q2
Revenue$15.9B-19.1%$19.7B+20.6%$16.3B-3.8%$17.0B+16.8%
Gross Profit$8.9B-25.0%$11.9B+27.4%$9.4B-6.2%$10.0B+24.2%
Operating Income----
Net Income$1.2B-78.3%$5.6B+221.1%$1.7B-20.5%$2.2B+108.0%

Columns use the calendar quarter of each reported period end date. QoQ is shown for adjacent company reporting quarters only.

AI Signal

Generated Jul 25, 2026

The Finlify signal for IBM is "AVOID," with a Finlify Score of 30.3 out of 100. This stance appears to be primarily driven by very low scores in Relative Strength (8.7/100) and Fundamental Trend (11.1/100), despite a strong Accumulation / Volume score.

Technical

The asset's technical posture appears weak, indicated by a very low Relative Strength score of 8.7/100. Recent performance shows a significant 20-day return of -21.4% and a 60-day return of -9.4%, suggesting downward momentum. The stock is also trading 37.2% below its 52-week high, with an RSI of 30.3, which may indicate it is approaching oversold conditions.

Fundamentals

Fundamental indicators suggest caution, with a very low Fundamental Trend score of 11.1/100 and a Financial Quality score of 38.8/100. While the asset offers a dividend yield of 3.27% and has a relatively low Beta of 0.7, its valuation metrics such as a P/E of 19.0x and P/B of 8.5x may warrant scrutiny given the weak fundamental trend.

Macro Context

The current macro environment, characterized by an elevated 10Y Treasury Yield of 4.7% and a narrow but positive yield spread of 0.4%, may present a challenging backdrop for growth-oriented or dividend-paying assets like IBM. Persistent inflation, with CPI YoY at 3.7%, could also impact corporate profitability and consumer spending, potentially affecting IBM's business outlook.

Key Risks

  • Weak Price Momentum: The asset exhibits very low Relative Strength (8.7/100) and significant recent price declines, including a -21.4% 20-day return.
  • Deteriorating Fundamental Trend: A very low Fundamental Trend score of 11.1/100 suggests potential concerns regarding the company's underlying business performance.
  • Post-Earnings Market Reaction: The asset's earnings were released on 2026-07-22, the day prior to this analysis, suggesting that market reaction to these results may still be unfolding.